TRAVERE THERAPEUTICS INC

CUSIP: 89422GAA5 Class: Convertible Debt

CAPSTONE INVESTMENT ADVISORS, LLC's Holding History (CIK: 0001426196)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 1,000,000 Value ($000) $1,427 Avg Close — Range —
Q4 2024
Shares 5,893,000 Value ($000) $5,642 Avg Close — Range —
Q3 2024
Shares 11,393,000 Value ($000) $9,844 Avg Close — Range —
Q2 2024
Shares 19,393,000 Value ($000) $12,630 Avg Close — Range —
Q1 2024
Shares 17,393,000 Value ($000) $11,036 Avg Close — Range —
Q4 2023
Shares 19,393,000 Value ($000) $12,799 Avg Close — Range —
Q3 2023
Shares 23,393,000 Value ($000) $15,177 Avg Close — Range —
Q2 2023
Shares 44,393,000 Value ($000) $35,709 Avg Close — Range —
Q1 2023
Shares 30,893,000 Value ($000) $30,368 Avg Close — Range —
Q4 2022
Shares 48,043,000 Value ($000) $43,959 Avg Close — Range —
Q3 2022
Shares 34,900,000 Value ($000) $35,685 Avg Close — Range —
Q2 2022
Shares 31,400,000 Value ($000) $31,494 Avg Close — Range —
Q1 2022
Shares 20,000,000 Value ($000) $21,290 Avg Close — Range —